Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.

from TechCrunch https://ift.tt/z5Vo6nq
via IFTTT

Comments

Popular posts from this blog

The best microwaves

Best weighted blankets

Tesla’s Dojo, a timeline